FDA, developmental biology, microbiology
Self-prescribing Patients?
Jef Akst | Mar 13, 2012
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Contributors
The Scientist Staff | Mar 1, 2012
Meet some of the people featured in the March 2012 issue of The Scientist.
Tricky Trials
Mary Beth Aberlin | Mar 1, 2012
Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.
How the Pediatric Laws Work
How the Pediatric Laws Work
Bob Grant | Mar 1, 2012
The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. 
How to Make Eyeball Stew
Hannah Waters | Mar 1, 2012
Editor's choice in developmental biology
Are the Kids Alright?
Are the Kids Alright?
Bob Grant | Mar 1, 2012
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
Model Citizen
Karen Hopkin | Mar 1, 2012
With an eye to understanding animal regeneration, Alejandro Sánchez Alvarado has turned a freshwater planarian into a model system to watch.
Biota Babble
Edyta Zielinska | Mar 1, 2012
Editor's choice in immunology
How Tigers Get Their Stripes
Bob Grant | Feb 22, 2012
For the first time researchers have demonstrated the molecular tango that gives rise to repeating patterns in developing animal embryos.
TB Screen Glows Green
Sabrina Richards | Feb 13, 2012
Infection by GFP-encoding viruses enables quick, easy detection of tuberculosis in patient samples.